Professor K Ray Chaudhuri
Professor K. Ray Chaudhuri is Professor of Neurology/Movement Disorders at King’s College Hospital and King’s College London and the Medical Director of the Parkinson Foundation International Centre of Excellence at King’s College. He is internationally known for pioneering modern care for people with Parkinson’s particularly advanced therapies in addition to care for restless legs syndrome. He is the founding Chairman of the International Movement Disorders Society Non-motor Study Group and member MDS-ES Education and palliative care committee and ex Chair of the MDS Membership and Public Relations committee as well as member MDS congress scientific programme committee (2013–2017).
Professor Chaudhuri is the author of over 430 papers, co-editor of five books on Parkinson’s disease and restless legs syndrome and winner of the BMA book prize commendation in 2015 and 2017. He won the Andrew Wilson Prize for services to RLS patients by RLS:UK, William Koller Memorial Fund Award by MDS, the 2018 Van Andel award in the USA for outstanding nonmotor research contribution in the field of nonmotor Parkinson, as well as NIHR/Royal College of Physicians London award for outstanding research leadership in 2017. In 2020 he was elected as lead for Equality Diversity charter for NIHR London South Applied Research Collaboration (ARC) and was elected as a honorary member for the Movement Disorders Society in 2021.
About Dr Vinod Metta
Dr Vinod Metta is a Consultant Interventional Neurologist and Movement Disorders, Dystonia, and Parkinson’s Specialist. He is a world-renowned expert in treating patients with advanced Parkinson’s disease & Pioneer in Novel Device aided Non-Oral therapies like Subcutaneous Apomorphine Pump & Intrajejunal Duodopa. He has successfully treated advanced Parkinson’s disease for more than a decade in the UK, India & Middle East.
Dr Vinod is one of few interventional neurologists who provide bespoke one-stop interventional procedures for a range of acute and chronic neurological & movement disorders and life-saving treatments like chemodenervation of Salivary glands for sialorrhea(hypersalivation) in patients with neurodegenerative diseases like Parkinson’s Disease, Huntington’s disease, Motor Neurone Disease, Multiple Sclerosis.
He trained at King’s College Hospital London and conducted his higher specialist training (CCT) in neurology and movement disorders at Imperial College London, University College London and Queen Square Hospitals in London. He is a member of the Association of British Neurologists (ABN) and Australian and New Zealand Association of Neurologists (ANZAN).
About Dr Guy Chung-Faye
Dr Guy Chung-Faye is a Consultant Gastroenterologist and Physician at King’s College Hospital, a London Teaching NHS Hospital and Academic Health Sciences Centre. He also practices at London Bridge Private Hospital and King’s College Hospital, Dubai, in the United Arab Emirates.
He is a medical graduate (MB ChB) of the University of Leicester Medical School and attained his PhD in “Gene therapy strategies in Colon cancer” from the University of Birmingham. He is a member of the Royal College of Physicians (MRCP) and the British Society of Gastroenterology (BSG).
He has extensive experience (over 20 years) in Gastroenterology and he is friendly and approachable and offers a holistic treatment approach to his patients. He sees patients with all aspects of Gastroenterology conditions and has specialist interests in Cancer, including Bowel Cancer Screening, Inflammatory Bowel Disease, Gastroenteritis, Irritable Bowel Syndrome, Dyspepsia & Reflux, Endoscopic Treatment of Obesity (Gastric Balloon) and Neuro-Gastroenterology. He is also part of the Advanced Therapies team, led by Dr Vinod Metta and Professor Ray Chaudhuri, treating patients with Parkinson’s disease with jejunal infusion of Levodopa.He is the Director of Bowel Cancer Screening and was previously the Clinical Lead in Upper GI (oesophageal & stomach) Cancer for over 15 years at King’s College Hospital. He is an expert in advanced endoscopy and a nationally accredited Bowel Cancer Screening Colonoscopist with a colonoscopy completion rate of over 95%, excellent polyp detection rates of over 50% and very high levels of patient comfort.
He has published in numerous peer-reviewed journals and he has written several book chapters. He is active in research and clinical trials in IBD, Cancer, Genetics and Neuro-Gastroenterology.